GE HealthCare Technologies Inc. (GEHC)
GE HealthCare Q2 Earnings Recap (Rating Downgrade)
GE HealthCare's Q2 earnings were disappointing, with revenue stagnating and cost efficiencies driving earnings, leading to a lowered price target and sell rating. The company continues to lag behind the market in various healthcare sectors, with AI potential diminishing and a decreased focus on R&D. Upside potential lies in the healthcare market and AI technology, but GEHC's slow progress and competition pose challenges for future growth.
Why GE HealthCare Technologies (GEHC) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
GE HealthCare (GEHC) Q2 Earnings Beat Estimates, Net Margin Up
GE HealthCare's (GEHC) second-quarter results witness declining segmental revenues in imaging, ultrasound and patient care. The bottom line improves on better pricing.
GE HealthCare Stock Surges as Profits Beat Estimates, Despite China Sales Headwinds
GE HealthCare (GEHC) shares rose over 4% in early trading Wednesday after the company reported second-quarter profits that beat analysts' estimates.
Here's What Key Metrics Tell Us About GE HealthCare (GEHC) Q2 Earnings
While the top- and bottom-line numbers for GE HealthCare (GEHC) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
GE HealthCare Technologies (GEHC) Tops Q2 Earnings Estimates
GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1 per share, beating the Zacks Consensus Estimate of $0.98 per share. This compares to earnings of $0.92 per share a year ago.
GE HealthCare's Stock Is Dropping After Earnings Beat. Here's Why.
GE HealthCare posts adjusted earnings per share of $1 in the second quarter, higher than estimates of 98 cents.
GE Healthcare's stock tumbles after revenue miss, free cash flow turns more negative
Shares of GE Healthcare Technologies Inc. GEHC tumbled 9.3% in premarket trading Wednesday, after the medical technologies and diagnostics company reported second-quarter revenue that missed expectations and cash flow that was more negative. Net income rose to $428 million, or 93 cents a share, from $418 million, or 91 cents a share, in the same period a year ago.
Lower Volume Likely to Hurt GE HealthCare's (GEHC) Q2 Earnings
GE HealthCare's (GEHC) second-quarter results are likely to witness declining segmental revenues in imaging, ultrasound and patient care. The bottom-line results may reflect better pricing.
3 Healthcare Stocks to Buy Now: Q3 Edition
After taking a backseat in the first half, the healthcare sector is finally coming to life. The rising odds of a Trump presidency have improved prospects for the industry, validating the case for increasing positions in healthcare stocks to buy now.
GE HealthCare (GEHC) New Deal to Aid Its Ultrasound Portfolio
GE HealthCare (GEHC) announces that it has entered into an agreement to acquire Intelligent Ultrasound's AI software business to strengthen its ultrasound portfolio.
GE HealthCare's (GEHC) New Solution to Aid Prostate Treatment
GE HealthCare's (GEHC) MIM Software introduced the MIM Symphony HDR Prostate to provide direct tumor visualization using MRI images during live ultrasound procedures for HDR prostate treatments.
